Articles dans des revues avec comité de lecture (196)
  1. 169. Marchant, A., Alegre, M.-L., Hakim, A., Pierard, G., Marecaux, G., Friedman, G., De Groote, D., Kahn, R., Vincent, J. L., & Goldman, M. (1995). Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. Journal of clinical immunology, 15(5), 266-273.
  2. 170. Fagny, C., Marchant, A., De Prez, E., Goldman, M., & Deschodt Lanckman, M. (1995). Lipopolysaccharide induces upregulation of neutral endopeptidase 24.11 on human neutrophils: involvement of the CD14 receptor. Clinical science, 89(1), 83-89.
  3. 171. Fouqueray, B., Boutard, V., Kornreich, C., Kornreich, A., Marchant, A., Perez, J. C., Goldman, M., & Baud, L. (1995). Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. The American journal of pathology, 147(1), 176-182.
  4. 172. Van Laethem, J.-L., Marchant, A., Delvaux, A., Goldman, M., Robberecht, P., Velu, T., & Devière, J. (1995). Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology, 108(6), 1917-1922. doi:10.1016/0016-5085(95)90158-2
  5. 173. Di Santo, E., Sironi, M., Pozzi, P., Gnocchi, P., Isetta, A., Delvaux, A., Goldman, M., Marchant, A., & Ghezzi, P. (1995). Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. Neuroimmunomodulation, 2(3), 149-154. doi:10.1159/000096885
  6. 174. van der Poll, T., Marchant, A., Buurman, W., Berman, L., Keogh, C. V., Lazarus, D. D., Nguyen, L., Goldman, M., Moldawer, L. L., & Lowry, S. F. (1995). Endogenous interleukin 10 protects mice from death during septic peritonitis. The Journal of immunology, 155, 5397-5401.
  7. 175. Derkx, B., Marchant, A., Goldman, M., Bijlmer, R., & van Deventer, S. (1995). High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. The Journal of infectious diseases, 171(1), 229-232. doi:10.1093/infdis/171.1.229
  8. 176. De Groote, D., Marchant, A., Fauchet, F., Jadoul, M., Dehart, I., Gérard, C., Gevaert, Y., Lopez, M., Gathy, R., & Franssen, J.-D. (1994). Characterisation of monoclonal antibodies against human interleukin-10 and their use in an ELISA for the measurement of this cytokine. Journal of immunological methods, 177(1-2), 225-234. doi:10.1016/0022-1759(94)90160-0
  9. 177. Le Moine, O., Marchant, A., Durand, F., Ickx, B., Pradier, O., Belghiti, J., Abramowicz, D., Gelin, M., Goldman, M., & Devière, J. (1994). Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology, 20(4), 889-892. doi:10.1002/hep.1840200417
  10. 178. Mengozzi, M., Fantuzzi, G., Marchant, A., Goldman, M., Orencole, S., Clark, B., Sironi, M., Benigni, F., & Ghezzi, P. (1994). Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology, 82(2), 207-210.
  11. 179. Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gérard, C., Delvaux, A., De Groote, D., Abramowicz, D., Velu, T., & Goldman, M. (1994). Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. European Journal of Immunology, 24(5), 1167-1171. doi:10.1002/eji.1830240524
  12. 180. Willems, F., Marchant, A., Delville, J. P., Gérard, C., Delvaux, A., Velu, T., de Boer, M., & Goldman, M. (1994). Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. European Journal of Immunology, 24(4), 1007-1009. doi:10.1002/eji.1830240435
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>